![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Financial & competing interests disclosure
In the past year, Jennifer Robinson has received research grants from Abbott, Bristol-Myers Squibb, Hoffman La Roche, Merck, Pfizer, Procter & Gamble, Schering-Plough, Aegerion, and Takeda. She has also received honoraria from Merck Schering Plough and is a consultant on the advisory boards of Astra-Zeneca and Merck Schering Plough.
Michael Davidson is on the speakers’ bureau of Abbott Laboratories, Astra Zeneca Pharmaceuticals, Kos Pharmaceuticals, Merck, Merck/Schering-Plough, Pfizer, Inc., Reliant Pharmaceuticals, Inc., Sankyo Pharma, and Takeda Pharmaceuticals. He is also a consultant for Abbott Laboratories, Astra Zeneca Pharmaceuticals, Kos Pharmaceuticals, Merck, Merck/Schering-Plough, Pfizer, Inc., Novartis, Reliant Pharmaceuticals, Inc., Roche Pharmaceuticals, Sankyo Pharma, Sumitomo Pharmaceuticals and Takeda Pharmaceuticals. He has also received grants and carried out research for Abbott Laboratories, Astra Zeneca Pharmaceuticals, Bristol-Myers Squibb, Kos Pharmaceuticals, Merck, Merck/Schering-Plough, Pfizer, Inc., Novartis, Reliant Pharmaceuticals, Inc., Roche Pharmaceuticals, Sankyo Pharma, and Takeda Pharmaceuticals.
The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.